Back to 
Quadrature Capital Ltd
Quadrature Capital Ltd
BTAIQ
1 quarters
Position history for Quadrature Capital Ltd's holdings in BioXcel Therapeutics, Inc.
Yes. Quadrature Capital holds 38,038 shares of BTAIQ (BioXcel Therapeutics), worth $53,634, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$53,634
Current Shares
38,038
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of BTAIQ: Millennium Management LLC, Oaktree Capital Management LP